Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial.
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.
The role of stress-response systems for the pathogenesis and progression of MS.
Incidence and prevalence of multiple sclerosis in southeastern Iran.
Identification of VHY/Dusp15 as a Regulator of Oligodendrocyte Differentiation through a Systematic Genomics Approach.
Oral BG-12 in multiple sclerosis.
Analysis of CD4+CD8+ double positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions.
Whole-Brain Diffusion Tensor Imaging in Correlation to Visual-Evoked Potentials in Multiple Sclerosis: A Tract-Based Spatial Statistics Analysis.
MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.
Neurotrophic factors and their effects in the treatment of multiple sclerosis.
The impact of walking speed on the effects of functional electrical stimulation for foot drop in people with multiple sclerosis.
CD8-mediated inflammatory central nervous system disorders.
A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients.
Axonal Loss in a Rat Model of Optic Neuritis Is Closely Correlated with Visual Evoked Potential Amplitudes Using Electroencephalogram-based Scaling.
Balance control in multiple sclerosis: Correlations of trunk sway during stance and gait tests with disease severity.
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams Study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial.
Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy.
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.
Antinuclear antibodies in pediatric acquired demyelinating diseases of the central nervous system.
[Neuromyelitis optica spectrum disorder: a case report].
[Transorbital echography for assessment of optical nerve atrophy in demyelinating diseases: a pilot study].
Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissue-based and cell-based indirect immunofluorescence assays and ELISA.
Haplotypes across the human caveolin 1 gene upstream purine complex significantly alter gene expression: Implication in neurodegenerative disorders.
Targeting intracerebral inflammation in multiple sclerosis: is it feasible?
Biologically plausible and evidence-based risk intervals in immunization safety research.

Pages